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A B S T R A C T
We aimed to assess clinical and laboratory differences between dengue and chikungunya in children
<24 months of age in a comparative study. We collected retrospective clinical and laboratory data
confirmed by NS1/IgM for dengue for 19 months (1 January 2013 to 17 August 2014). Prospective
data for chikungunya confirmed by real-time polymerase chain reaction were collected for 4 months
(22 September 2014–14 December 2014). Sensitivity and specificity [with 95% confidence interval
(CI)] were reported for each disease diagnosis. A platelet count <150 000 cells/ml at emergency
admission best characterized dengue, with a sensitivity of 67% (95% CI, 53–79) and specificity of
95% (95% CI, 82–99). The algorithm developed with classification and regression tree analysis
showed a sensitivity of 93% (95% CI, 68–100) and specificity of 38% (95% CI, 9–76) to diagnose
dengue. Our study provides potential differential characteristics between chikungunya and dengue
in young children, especially low platelet counts.
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I N T R O D U C T I O N
Dengue and chikungunya are viruses most com-
monly transmitted by the mosquito vectors Aedes
aegypti and Aedes albopictus, disseminating both
diseases in tropical settings worldwide [1]. Some
patients infected with dengue may develop life-
threatening consequences and require hospitaliza-
tion, while the acute symptoms of patients infected
with chikungunya may resolve within 7–14 days.
Dengue is an emerging tropical disease that caused
96 million apparent new infections worldwide in
2010 [2], and a third of these infections required
health-care attention [2]. The co-circulation of
dengue and chikungunya has been confirmed in
at least 98 countries/territories worldwide [1]. In
Colombia, the co-circulation started in 2014 when
chikungunya arrived to the country in a town near
Cartagena [3].
Chikungunya fever can be indistinguishable at
early ages from dengue and other viruses (e.g. Zika,
Mayaro and Oropouche) [4], hence the need for
proper diagnosis in children. In tropical settings,
where both dengue and chikungunya are endemic,
the laboratory confirmation of chikungunya is prob-
lematic, as virological/serological tests needed to
make proper diagnosis may not be readily available.
The differentiation between dengue and chikungu-
nya in rural and low-income settings is of special
importance because dengue may rapidly worsen clin-
ical condition, leading to dengue shock and poten-
tially death, while chikungunya rarely produces
severe disease.
Colombia is 1 of 10 countries with most reported
dengue cases, according to different estimations
[2, 5]. Chikungunya was introduced by mid-2014
in the country, with no confirmed case before
September 2014 [6]. In the present study, we assess
the key clinical and laboratory differences between
hospitalized chikungunya and dengue in children
<24 months of age from Colombia.
P A T I E N T S A N D M E T H O D S
We carried out a comparative study to assess clinical
and laboratory differences between chikungunya and
dengue. We collected data from Hospital Infantil
Napoleon Franco Pareja—La Casa del Ni~no
(HINFP), a pediatric university hospital from
Cartagena (a city of around 1 million people located in
northern tropical Colombia, South America), which
serves lower-middle-income and low-income popula-
tion, with around-the-clock physicians, including resi-
dents, intensivists and infectious disease pediatricians.
Co-circulation of dengue and chikungunya began
in Colombia in September 2014.
We conducted a retrospective study of confirmed
cases of dengue between 1 January 2013 and 17
August 2014 [7], when chikungunya was not circu-
lating in the country. Then, as chikungunya was
entering Latin America and the Caribbean, and circu-
lation was confirmed in Colombia, we had a unique
opportunity to highlight differences in clinical mani-
festation and management between chikungunya and
dengue in infants and children of our setting, an
upper-middle-income country with a gross domestic
product per capita of US$13.357 Power Purchasing
Parity in 2014 [8].
We designed an analysis to compare our retrospec-
tive cohort of confirmed dengue cases before
September 2014 (our dengue patients) with the pro-
spective cohort of confirmed chikungunya cases after
September 2014 (our chikungunya patients). We did
not assess co-infection with dengue and chikungunya.
The analyses included patients between 0 and
24 months of age. These patients were excluded because
an analysis of our chikungunya patients [4] showed that
neonates and infants of lower age had more severe dis-
ease, making more likely the need for hospitalization.
This highlights the need in these patients of a clearer
diagnostic pathway to differentiate dengue and chikun-
gunya in countries with co-circulation. All patients
included in the sample were admitted to the emergency
department, after which they may or may have not
needed hospitalization at HINFP. Hospitalization was
defined as at least an overnight stay at the health institu-
tion. The ethics committee of HINFP approved both
data collections.
The Supplementary Material describes our data
collection methods for both dengue and chikungu-
nya patients. The flowchart of the sample size is
shown in Fig. 1.
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Study variables and data analysis
For both children with dengue and chikungunya, we
collected information about age, gender, time of
onset of symptoms, clinical signs at admission
(ascites, pleural effusion and vomit), vital signs at
admission (temperature, systolic blood pressure and
diastolic blood pressure), laboratory values at admis-
sion (platelets, hemoglobin, hematocrit and white
blood cell count) and need of critical care or not
during hospital stay.
For variable description, categorical variables were
reported in percentages and continuous variables in
median with interquartile range (IQR) as dispersion
measure. Analyses were made in Stata (Stata v. 13
for Windows; StataCorp; TX, USA) and R statistical
software.
The Supplementary Material also expands our
data analysis section.
R E S U L T S
Characteristics of the sample
A total of 57 children with dengue and 37 children
with chikungunya were admitted to the emergency
department (Fig. 1). Age differed between cases of
dengue and chikungunya (p< 0.001). Median age
was 12 months (IQR, 8.4–13.2) in patients with
dengue, and 1.2 months (IQR, 1.2–3.6) in patients
with chikungunya. We collected 11 of 37 (30%) neo-
nates with chikungunya; no cases of neonatal dengue
were reported. A total of 34 males (60%) with
dengue and 22 males (59%) with chikungunya pre-
sented to the emergency department (p¼ 0.985).
Median time with symptoms before emergency
admission was 5.0 days (IQR, 4.0–6.0) in dengue
patients and 1.0 days (IQR, 1.0–3.0) in patients with
chikungunya. The time with symptoms before emer-
gency admission was different between children with
dengue and chikungunya (p< 0.001).
Figure 1 shows the median and IQR of children
with dengue or chikungunya by days with symptoms
before emergency department admission. Figure 2
and Table 1 show that platelet count increased sig-
nificantly. In the crude analysis, we found differences
in the presence of diarrhea, hemoglobin decreased
for age, white blood cells decrease for age and plate-
lets, between cases with dengue and controls with
chikungunya (Table 1).
In multivariable logistic regression (adjusted by
age, sex and time with symptoms previous to
admission), only platelet count was significantly dif-
ferent between dengue and chikungunya (Table 1).
Clinical characteristics were found to not be signifi-
cantly different.
Diagnosis of dengue
An assessment of cutoff values for these variables
with the greatest AUC is reported in Table 2. The
characteristic that best diagnosed dengue was a plate-
let count <150 000 cells per mm3 at emergency
admission, with an AUC of 0.81 [95% confidence
interval (CI), 0.73–0.88], a sensitivity of 67% (95%
CI, 53–79) and specificity of 95% (95% CI, 82–99).
Algorithm to differentiate dengue and chikungunya
Data were randomly split into two data sets. The
training data set was composed of 56 children and
the testing data set composed of 23 children. The
model used values of hematocrit, platelet and white
blood cells collected at emergency admission to pre-
dict dengue in the sample.
The model that used 10 observations as minimum
in each split had an AUC of 0.75 (95% CI, 55–96),
with 15 minimum observations in each split, the
AUC was 0.77 (95% CI, 57–97) and with 20 mini-
mum observations in each split, the AUC was 0.74
(95% CI, 0.54–0.94).
The final model used 15 minimum observations
in each split because of its higher AUC. The result-
ing model is shown in Fig. 3. In summary, two
groups of children were classified as having dengue:
Fig. 1. Flowchart for patient inclusion in the study.
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1. Platelets <168 000 cells/ml.
2. Platelets 168 000 cells/ml, and white
blood cell count between 5300 and 12 000
cells/ml.
The diagnostic assessment of the final tree showed
a sensitivity of 93% (95% CI, 68–100) and
specificity of 38% (95% CI, 9–76) to diagnose
dengue, a positive predictive value of 74% (95% CI,
49–91) and a negative predictive value of 75% (95%
CI, 19–99).
D I S C U S S I O N
Our analyses suggest that a few key simple laboratory
variables may be valuable for differential diagnosis
between chikungunya and dengue in infants and
children that need admission to the emergency
department, evidencing that platelets <150 000 cells
per ml would only miss one of three cases with
dengue, and the algorithm including platelets and
white blood cell count would miss only 7 in 100
cases with dengue. This is important to the health-
care worker in low-income or rural settings without
access to rapid tests/laboratory confirmation of
dengue because these low-level health-care facilities
may advert deaths and disability by safely remitting
patients with high index of dengue suspicion to
higher levels of care.
Our study also highlights that for conclusive dif-
ferentiation between dengue and chikungunya that
needs hospitalization, clinical/laboratory variables
alone may not be as useful, and confirmation
through rapid tests or other methods may be needed
for a better clinical management.
Fig. 2. Median and IQR of children with dengue or chikungunya by duration of symptoms.
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Table 1. Clinical and laboratory characteristics of chikungunya and dengue and their relative adjusted
risks among children <24 months of age in Colombia
Characteristics Crude analysis Risks for dengue
Chikungunya Dengue p-value Adjusted odds
ratio (95% CI)*
Clinical
Diarrhea, n (%) 3/37 (8) 13/57 (23) 0.064 2.13 (0.29–15.66)
Ascites, n (%) 0/37 (0) 1/57 (2) 1.000** N.E.




10.5 (10–12) [36] 10.5 (10–12) [53] 0.910
Decrease for age, n (%) 26/36 (72) 25/53 (47) 0.019 1.33 (0.26–6.87)
Increase for age, n (%) 0/36 (0) 1/53 (2) 1.000** N.E.
Hematocrit (%) median (IQR) [n] 30.9 (29–34) [33] 31.5 (30–35) [52] a. 0.510
Decrease for age, n (%) 24/33 (73) 30/52 (58) 0.160 1.04 (0.26–4.19)
Increase for age, n (%) 0/33 (0) 1/52 (2) 1.000** N.E.
White blood cells (1000 cells/ml)
median (IQR) [n]
6.4 (5–10) [33] 7.4 (5–12) [53] 0.220
Decrease for age, n (%) 17/33 (52) 16/53 (30) 0.048 0.28 (0.07–1.08)
Increase for age, n (%) 4/33 (12) 5/53 (9) 0.728 1.97 (0.27–14.17)
Platelets (1000 cells/ml) median
(IQR) [n]
256.0 (213–335) [34] 106.0 (80–164) [53] <0.001 0.22 (0.05–0.87)***
Note: N.E.: Not estimable.
*Adjusted by age, days with symptoms and sex.
**Fisher’s exact test.
***Best fit was natural logarithm of the exposure variable.
Table 2. Prognostic value of parameters for dengue diagnosis of children <24 months old
Parameters at emergency admission Sensitivity (%) (95% CI) Specificity (%) (95% CI) AUC (95% CI)
Platelets (cells/ml)
<100 000 40 (28–54) 97 (86–100) 0.69 (0.62–0.76)
<150 000 67 (53–79) 95 (82–99) 0.81 (0.73–0.88)
<200 000 74 (60–84) 84 (68–94) 0.79 (0.70–0.87)
White blood cell count
High for age 91 (79–97) 12 (3–28) 0.51 (0.44–0.58)
Low for age 70 (56–82) 52 (34–69) 0.61 (0.50–0.71)
Hematocrit
High for age 2 (0–10) 100 (89–100) 0.51 (0.49–0.53)
Low for age 42 (29–57) 73 (54–87) 0.58 (0.47–0.68)
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The arrival of Zika in 2015 to the region may
complicate differential diagnosis of fever of unknown
origin. In pediatric chikungunya, and especially at
younger ages, arthralgia and arthritis cannot be prop-
erly assessed despite being hallmarks of chikungunya
[4], and the laboratory diagnosis of chikungunya or
Zika is still uncommon in our region. The clear dif-
ferentiation between dengue, chikungunya and Zika
in their acute clinical presentation is important for
health-care clinical workers and decision-makers;
currently, a patient must undergo several tests to dif-
ferentiate between these three diseases in a burden-
some and costly process.
A call is warranted for a rapid test or cheap labo-
ratory tests with adequate sensitivity and specificity
to diagnose dengue, chikungunya and/or Zika,
including tools to detect co-infection of patients.
The highest burden of these three diseases is set
in low- and lower-middle-income regions throughout
tropical climates [9]. Adequate identification of acute
disease will lead to better knowledge on the specific
burden of each disease, helping decision-makers to
redirect policies to lower the mortality and disability
in regions that need this the most.
A recent case series from Colombia showed that
vertical transmission of chikungunya can lead to
severe disease in the neonate [10]. Although in the
present study chikungunya vertical transmission was
not confirmed, we cannot rule it out in some
patients, given the age of diagnosis. The age differ-
ence between the two cohorts can alter physiologic
normal values for some variables. For platelets,
previous literature does not suggest that normal
values change throughout life [11]. We adjusted
all other parameters for age to account for these
differences.
Our main limitation is that patients with dengue
and chikungunya were not ascertained in the same
timeframe, allowing for some source of information
bias and selection bias. Laboratory tests, like platelet
counts, were conducted at different time points for
dengue and chikungunya patients, and by different
technicians and using different equipment. It could
lead, up to some point, to differences in results
between the two groups explained by procedural dif-
ferences. Though this source of bias is potentially
present, it is unlikely to fully explain the large differ-
ences in platelet accounts that we found in the study.
Also, we were not able to select patients with co-
infection. Despite this, we confirmed all patients
through laboratory test, and we think it is unlikely
that the severity profiles of the diseases would
change in our analyzed timeframes. Our sample of
children with dengue did not include patients with
chikungunya because in that timeframe, chikungunya
was not circulating in Colombia. For the timeframe
of the chikungunya data collection, the high specific-
ity in the literature of the dengue tests (>94%)
(10–14) makes false positives unlikely, but the rela-
tive low sensitivity of rapid methods for dengue
may mask some dengue/chikungunya co-infections
among the chikungunya group. This potential infor-
mation bias would decrease the magnitude of the
relationship between platelet counts and dengue;
Fig. 3. Algorithm for differential diagnosis of chikungunya and dengue in children under 24 months old in Colombia.
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thus, it would not explain the differences we found.
If something, the difference may well be larger if bet-
ter dengue diagnosis tests had been available. Other
limitations are related to selection, information and
misclassification bias, especially for the children with
dengue. Selection bias may be possible for dengue
because confirmation was made with rapid tests.
However, the rapid tests we used have a good sensi-
tivity and high specificity. Information bias may be
also possible for the dengue patients because data
collection was retrospective; however, trained health
personal (who usually care for dengue patients) sys-
tematically gathered data for all patients in our
research. The chikungunya data are prospective, and
so, information bias is unlikely.
Chikungunya and dengue are two under-
researched emerging diseases. Further, evidence-
based medicine and translation research are needed
to curve down endemicity and disease burden world-
wide. The uncertainty in the differential diagnosis of
Chikungunya and dengue and the emergency of Zika
as a disease with increased disability renew calls for
proper diagnostic tests for these diseases.
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